Combination of PD‐1/PD‐L1 checkpoint inhibition and dendritic cell therapy in mice models and in patients with mesothelioma

por van Gulijk, Mandy, Belderbos, Bob, Dumoulin, Daphne, Cornelissen, Robin, Bezemer, Koen, Klaase, Larissa, Dammeijer, Floris, Aerts, Joachim
Publicado 2022

Immunomodulatory Effects of Stereotactic Body Radiotherapy and Vaccination with Heat-Killed Mycobacterium Obuense (IMM-101) in Patients with Locally Advanced Pancreatic Cancer

por van ‘t Land, Freek R., Lau, Sai P., de Koning, Willem, Klaase, Larissa, Vink, Madelief, van Krimpen, Anneloes, Dumas, Jasper, Vadgama, Disha, Nuyttens, Joost J., Mustafa, Dana A. M., Stadhouders, Ralph, Willemsen, Marcella, Stubbs, Andrew P., Aerts, Joachim G., van Eijck, Casper H. J.
Publicado 2022

Immune monitoring in mesothelioma patients identifies novel immune-modulatory functions of gemcitabine associating with clinical response

por Dammeijer, Floris, De Gooijer, Cornedine J., van Gulijk, Mandy, Lukkes, Melanie, Klaase, Larissa, Lievense, Lysanne A., Waasdorp, Cynthia, Jebbink, Merel, Bootsma, Gerben P., Stigt, Jos A., Biesma, Bonne, Kaijen-Lambers, Margaretha E.H., Mankor, Joanne, Vroman, Heleen, Cornelissen, Robin, Baas, Paul, Van der Noort, Vincent, Burgers, Jacobus A., Aerts, Joachim G.
Publicado 2021

Dendritic cell vaccination and CD40-agonist combination therapy licenses T cell-dependent antitumor immunity in a pancreatic carcinoma murine model

por Lau, Sai Ping, van Montfoort, Nadine, Kinderman, Priscilla, Lukkes, Melanie, Klaase, Larissa, van Nimwegen, Menno, van Gulijk, Mandy, Dumas, Jasper, Mustafa, Dana A M, Lievense, Sanne L A, Groeneveldt, Christianne, Stadhouders, Ralph, Li, Yunlei, Stubbs, Andrew, Marijt, Koen A, Vroman, Heleen, van der Burg, Sjoerd H, Aerts, Joachim, van Hall, Thorbald, Dammeijer, Floris, van Eijck, Casper H J
Publicado 2020